Again and again, the FDA tolerated substandard manufacturing at a Sun Pharma factory after the company promised to make changes, according to documents obtained by ProPublica. The medications kept flowing to the U.S. market.

A Giant Indian Drugmaker Failed to Fix Safety Breaches. The FDA Let It Off the Hook Again and Again.
Documents obtained by ProPublica offer a rare glimpse into discussions between the global drugmaker Sun Pharma and the FDA, exposing how the agency tolerated substandard manufacturing for years.